Elevated sphingosine-1-phosphate promotes sickling and sickle cell disease progression
Yujin Zhang, Yang Xia(Northcentral University), Vladimír Berka(The University of Texas Health Science Center at Houston), Martin K. Safo(Virginia Commonwealth University), Mikhail Bogdanov(The University of Texas Health Science Center), Ah‐Lim Tsai(The University of Texas Health Science Center at Houston), Qibo Zhang, Pumin Zhang(Guangxi Medical University), Michael V. Milburn(Unknown), Mostafa H. Ahmed(Virginia Commonwealth University), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Gregory J. Kato(RED Consulting (Norway)), Chonghua Li(The University of Texas Health Science Center at Houston), Kaiqi Sun(The University of Texas Health Science Center at Houston), Anren Song(The University of Texas Health Science Center), Modupe Idowu(The University of Texas Health Science Center at Houston), Wei Wang(Central South University), Jun Zhang(Jiangsu University), Wenzheng Zhang(Affiliated Hospital of Hangzhou Normal University), Ning Chen(Lund University), Jianping Jin, Danny C. Alexander(Metabolon (United States)), Harinder S. Juneja(The University of Texas Health Science Center at Houston), Weiru Zhang(Central South University), William Dowhan(The University of Texas Health Science Center), Lin Han, Rodney E. Kellems(Baylor College of Medicine)
Cited by 2
Related Papers
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
Sickle cell disease
|Nature Reviews Disease Primers|2018|1.4k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k